Placeholder canvas
Date: March 29, 2019

Foley & Mansfield Partner Melissa Roeder Chairing DRI Cannabis Seminar May 15 DRI Program to Address Evolving Issues in Cannabis Law

by foleyandmansfield
Date: March 29, 2019
by foleyandmansfield

Foley & Mansfield Partner Melissa Roeder Chairing DRI Cannabis Seminar May 15 DRI Program to Address Evolving Issues in Cannabis Law

Placeholder canvas

What do you get when 10 states fully legalize marijuana, 33 states have legalized medicinal marijuana and all but four states have legalized hemp and/or CBD?  You get a personal invitation to attend the 2019 DRI Cannabis Seminar to be held on May 15, 2019 in Washington, D.C.

Foley & Mansfield is pleased to be a sponsor of this innovative DRI program, chaired by firm partner Melissa Roeder. The program will cover developing litigation issues involving the cannabis industry – national and state perspectives, expert insight on fire science and toxicologist, information on bankruptcy protection and a perspective from an insurance panel. 

Be on the cutting edge of cannabis litigation and join us on May 15, 2019. For details or to register, visit DRI.

Melissa K. Roeder

Go back to news

Amended FRE 702 Creates Path for Expert Challenges in Talc Litigation

A recent update to the federal rules governing the use of expert testimony/evidence in federal court will widely impact how scientific and medical evidence is presented to juries in federal matters, including talcum powder litigation. With the change to Rule 702 of the Federal Rules of Evidence (“FRE 702”), defendants […]

LEARN MORE

Summarizing “ILR Briefly: The Asbestos Over-Naming and Trust Transparency Problem: A Philadelphia Case Study”

Introduction Asbestos litigation has become a cornerstone of the American legal landscape, spanning over four decades, and involving more than a million individual personal injury claims across state and federal courts. In 2012, a commentary titled “The Philadelphia Story: Asbestos Litigation, Bankruptcy Trusts, and Changes in Exposure Allegations from 1991-2010” […]

LEARN MORE

Minnesota Legislature Seeks to Change Newly Effective Earned Safe and Sick Time Law

By now, employers should be familiar with and implementing (if applicable) Minnesota’s Earned Safe and Sick Time law (“ESST”) that took effect on January 1, 2024. ESST is paid leave that an employee may use when they or a family member are sick, need to see a doctor or medical […]

LEARN MORE

Amended FRE 702 Creates Path for Expert Challenges in Talc Litigation

A recent update to the federal rules governing the use of expert testimony/evidence in federal court will widely impact how scientific and medical evidence is presented to juries in federal matters, including talcum powder litigation. With the change to Rule 702 of the Federal Rules of Evidence (“FRE 702”), defendants […]

LEARN MORE

Summarizing “ILR Briefly: The Asbestos Over-Naming and Trust Transparency Problem: A Philadelphia Case Study”

Introduction Asbestos litigation has become a cornerstone of the American legal landscape, spanning over four decades, and involving more than a million individual personal injury claims across state and federal courts. In 2012, a commentary titled “The Philadelphia Story: Asbestos Litigation, Bankruptcy Trusts, and Changes in Exposure Allegations from 1991-2010” […]

LEARN MORE

Minnesota Legislature Seeks to Change Newly Effective Earned Safe and Sick Time Law

By now, employers should be familiar with and implementing (if applicable) Minnesota’s Earned Safe and Sick Time law (“ESST”) that took effect on January 1, 2024. ESST is paid leave that an employee may use when they or a family member are sick, need to see a doctor or medical […]

LEARN MORE
Browse all articles